Personal information

United States

Activities

Employment (3)

Merck : Boston, MA, US

2018-05 to present | Director (Discovery Chemistry)
Employment
Source: Self-asserted source
Kaustav Biswas

Amgen Inc: Thousand Oaks, CA, US

2002-09 to 2018-05 | Group Leader/Principal Scientist (Discovery Research)
Employment
Source: Self-asserted source
Kaustav Biswas

Memorial Sloan-Kettering Cancer Center: New York, NY, US

2000 to 2002 | Post Doctoral Fellow (Laboratory for Bioorganic Chemistry)
Employment
Source: Self-asserted source
Kaustav Biswas

Education and qualifications (1)

Princeton University: Princeton, NJ, US

2000 | PhD (Chemistry)
Education
Source: Self-asserted source
Kaustav Biswas

Works (12)

Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1

Journal of Medicinal Chemistry
2016 | Journal article
Source: Self-asserted source
Kaustav Biswas

Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1

Bioorganic and Medicinal Chemistry Letters
2015 | Journal article
Source: Self-asserted source
Kaustav Biswas

Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell Viability

ACS Medicinal Chemistry Letters
2015 | Journal article
Source: Self-asserted source
Kaustav Biswas

Discovery of Clinical Candidate 1-(4-(3-(4-(1H-Benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), A Potent, Selective, and Efficacious Inhibitor of Phosphodiesterase 10A (PDE10A)

Journal of Medicinal Chemistry
2014 | Journal article
Source: Self-asserted source
Kaustav Biswas

Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer’s disease

Bioorganic and Medicinal Chemistry Letters
2013 | Journal article
Source: Self-asserted source
Kaustav Biswas

3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation

Bioorganic and Medicinal Chemistry Letters
2011 | Journal article
Source: Self-asserted source
Kaustav Biswas

Discovery of Potent, Orally Bioavailable Phthalazinone Bradykinin B1 Receptor Antagonists

Journal of Medicinal Chemistry
2011 | Journal article
Source: Self-asserted source
Kaustav Biswas

Aryl sulfones as novel Bradykinin B1 receptor antagonists for treatment of chronic pain

Bioorganic and Medicinal Chemisty letters
2008 | Journal article
Source: Self-asserted source
Kaustav Biswas

Potent Nonpeptide Antagonists of the Bradykinin B1 Receptor:  Structure−Activity Relationship Studies with Novel Diaminochroman Carboxamides

Journal of Medicinal Chemistry
2007 | Journal article
Source: Self-asserted source
Kaustav Biswas

Highly Concise Routes to Epothilones:  The Total Synthesis and Evaluation of Epothilone 490

Journal of the American Chemical Society
2002 | Journal article
Source: Self-asserted source
Kaustav Biswas

Calicheamicin−DNA Recognition:  An Analysis of Seven Different Drug−DNA Complexes

Journal of the American Chemical Society
2000 | Journal article
Source: Self-asserted source
Kaustav Biswas

The Molecular Basis for Pyrimidine-Selective DNA Binding:  Analysis of Calicheamicin Oligosaccharide Derivatives by Capillary Electrophoresis

Journal of the American Chemical Society
2000 | Journal article
Source: Self-asserted source
Kaustav Biswas

Peer review (12 reviews for 3 publications/grants)

Review activity for ACS medicinal chemistry letters. (1)
Review activity for ACS omega. (1)
Review activity for Journal of medicinal chemistry. (10)